WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Immuneering revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMRX annual revenue was $0.0, with N/A growth year-over-year.

IMRX past revenue growth

How has IMRX's revenue growth performed historically?

Company
N/A
Industry
437.31%
Market
20.27%
IMRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IMRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

IMRX revenue history

Current Revenue
$0.0
Current Earnings
-$61.0M
Current Profit Margin
0%

Be the first to know when IMRX announces revenue.

IMRX Revenue History By Year

IMRX Yearly RevenueIMRX RevenueIMRX ChangeIMRX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00-$316.95k-100.00%
2022-12-31$316.95k-$1.76M-84.76%
2021-12-31$2.08M-$231.57k-10.02%
2020-12-31$2.31M$391.83k+20.41%
2019-12-31$1.92MN/AN/A

1 of 1

Immuneering Revenue FAQ

What was IMRX's revenue last quarter?

Immuneering (NASDAQ: IMRX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Immuneering's revenue was $0.00.

What was Immuneering's revenue in 2024?

Immuneering's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Immuneering make in a day?

Based on Immuneering annual revenue for the past five years, IMRX makes an average of $2,579.97 per day.

What was Immuneering's annual revenue growth in the past year?

As of Q2 2025, Immuneering's revenue has grown null year over year. Immuneering's revenue in the past year totaled $0.00.

How much does Immuneering make in a year?

Immuneering's revenue by year for the past five years is:
  • Immuneering's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Immuneering's annual revenue for Dec 31, 2023 was $0.00, a 100% decrease from 2022.
  • Immuneering's annual revenue for 2022 was $316.95 thousand, a 84.76% decrease from 2021.
  • Immuneering's annual revenue for 2021 was $2.08 million, a 10.02% decrease from 2020.
  • Immuneering's annual revenue for 2020 was $2.31 million, a 20.41% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.